Abstract
This review analyzes data regarding liver injury associated with COVID-19 infection. We discuss reported effects on the liver from both COVID-19 and COVID-19 treatment as well as pathophysiology, review the potential role of drug-induced liver injury as an etiology of COVID-19-associated liver injury, and touch on other reports of significant outcomes including COVID-19 cholangiopathy and autoimmune hepatitis. Finally, we review the implications of COVID-19 infection in liver transplant recipients.
Cite
CITATION STYLE
Gildea, D. T., Woo, S. M., O’Connor, C. E., & Rangnekar, A. S. (2023). COVID-19-Associated Liver Injury. Hepatic Medicine: Evidence and Research, Volume 15, 1–9. https://doi.org/10.2147/hmer.s384108
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
